301 related articles for article (PubMed ID: 28239636)
1. Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis.
Baker JE; Lim YY; Pietrzak RH; Hassenstab J; Snyder PJ; Masters CL; Maruff P
Alzheimers Dement (Amst); 2017; 6():108-121. PubMed ID: 28239636
[TBL] [Abstract][Full Text] [Related]
2. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of amyloid-cognition relations in cognitively normal older adults.
Hedden T; Oh H; Younger AP; Patel TA
Neurology; 2013 Apr; 80(14):1341-8. PubMed ID: 23547267
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score.
Lim YY; Snyder PJ; Pietrzak RH; Ukiqi A; Villemagne VL; Ames D; Salvado O; Bourgeat P; Martins RN; Masters CL; Rowe CC; Maruff P
Alzheimers Dement (Amst); 2016; 2():19-26. PubMed ID: 27239532
[TBL] [Abstract][Full Text] [Related]
5. Plasma Cortisol, Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer's Disease: A 6-Year Prospective Cohort Study.
Pietrzak RH; Laws SM; Lim YY; Bender SJ; Porter T; Doecke J; Ames D; Fowler C; Masters CL; Milicic L; Rainey-Smith S; Villemagne VL; Rowe CC; Martins RN; Maruff P;
Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Jan; 2(1):45-52. PubMed ID: 29560886
[TBL] [Abstract][Full Text] [Related]
6. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.
Pietrzak RH; Lim YY; Neumeister A; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Restrepo C; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P;
JAMA Psychiatry; 2015 Mar; 72(3):284-91. PubMed ID: 25629787
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of the Preclinical Alzheimer's Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheimer's Disease -Atabecestat Phase 2b/3 EARLY Clinical Trial.
Papp KV; Rofael H; Veroff AE; Donohue MC; Wang S; Randolph C; Grober E; Brashear HR; Novak G; Ernstrom K; Raman R; Aisen PS; Sperling R; Romano G; Henley D
J Prev Alzheimers Dis; 2022; 9(2):255-261. PubMed ID: 35542998
[TBL] [Abstract][Full Text] [Related]
8. Inter-network connectivity and amyloid-beta linked to cognitive decline in preclinical Alzheimer's disease: a longitudinal cohort study.
Van Hooren RWE; Riphagen JM; Jacobs HIL;
Alzheimers Res Ther; 2018 Aug; 10(1):88. PubMed ID: 30153858
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.
Bransby L; Lim YY; Ames D; Fowler C; Roberston J; Harrington K; Snyder PJ; Villemagne VL; Salvado O; Masters CL; Maruff P
J Clin Exp Neuropsychol; 2019 Aug; 41(6):591-600. PubMed ID: 30924399
[No Abstract] [Full Text] [Related]
10. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
[TBL] [Abstract][Full Text] [Related]
11. Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.
Baker JE; Lim YY; Jaeger J; Ames D; Lautenschlager NT; Robertson J; Pietrzak RH; Snyder PJ; Villemagne VL; Rowe CC; Masters CL; Maruff P
J Alzheimers Dis; 2018; 65(3):977-988. PubMed ID: 30103330
[TBL] [Abstract][Full Text] [Related]
12. Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease.
Lim YY; Ellis KA; Harrington K; Kamer A; Pietrzak RH; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Ames D; Maruff P;
Neuropsychology; 2013 May; 27(3):322-332. PubMed ID: 23688214
[TBL] [Abstract][Full Text] [Related]
13. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
[TBL] [Abstract][Full Text] [Related]
14. Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-β: prodromal Alzheimer's disease?
Lim YY; Ellis KA; Harrington K; Pietrzak RH; Gale J; Ames D; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Maruff P
J Alzheimers Dis; 2013; 33(4):1167-76. PubMed ID: 23160011
[TBL] [Abstract][Full Text] [Related]
15. Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults.
Dang C; Harrington KD; Lim YY; Ames D; Hassenstab J; Laws SM; Yassi N; Hickey M; Rainey-Smith SR; Robertson J; Rowe CC; Sohrabi HR; Salvado O; Weinborn M; Villemagne VL; Masters CL; Maruff P;
Arch Clin Neuropsychol; 2019 Jul; 34(5):585-598. PubMed ID: 30272115
[TBL] [Abstract][Full Text] [Related]
16. Decline in cognitive function over 18 months in healthy older adults with high amyloid-β.
Ellis KA; Lim YY; Harrington K; Ames D; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Maruff P;
J Alzheimers Dis; 2013; 34(4):861-71. PubMed ID: 23302660
[TBL] [Abstract][Full Text] [Related]
17. Cognitively normal women with Alzheimer's disease proteinopathy show relative preservation of memory but not of hippocampal volume.
Caldwell JZK; Cummings JL; Banks SJ; Palmqvist S; Hansson O
Alzheimers Res Ther; 2019 Dec; 11(1):109. PubMed ID: 31878968
[TBL] [Abstract][Full Text] [Related]
18. Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5.
Papp KV; Rentz DM; Orlovsky I; Sperling RA; Mormino EC
Alzheimers Dement (N Y); 2017 Nov; 3(4):668-677. PubMed ID: 29264389
[TBL] [Abstract][Full Text] [Related]
19. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
[TBL] [Abstract][Full Text] [Related]
20. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
